Navigation Links
Better cholesterol drugs may follow Saint Louis University researcher's breakthrough
Date:10/5/2010

ST. LOUIS Thanks to a discovery by a Saint Louis University researcher, scientists have identified an important microRNA that may allow us to better control cholesterol levels in blood.

Led by ngel Baldn, Ph.D., assistant professor of biochemistry and molecular biology at Saint Louis University and published in a recent issue of Proceedings of the National Academy of Sciences of the United States of America, the study found that the microRNA miR-33, may be key to controlling HDL, or "good" cholesterol levels.

In the U.S., heart attack, stroke, and peripheral artery disease collectively account for more than 30 percent of all deaths in the last decade. Atherosclerosis, the fatty build-up in arteries that causes these illnesses, is tied to cholesterol levels, a waxy substance found in the blood.

Statins, drugs frequently prescribed by doctors to manage cholesterol levels, work by lowering LDL, or "bad" cholesterol levels; however, their role in HDL cholesterol is still obscure. Importantly, HDL has been found to have a protective benefit against cardiovascular disease.

"Atherosclerosis costs lives and takes an enormous toll on our health," said Baldn. "If the discovery that miR-33 can be used to raise HDL levels leads to better medications, it will have an enormous impact on our ability to treat heart disease."

The study, which was funded by the National Institutes of Health, Saint Louis University Center for Cardiovascular Research and the Doisy Department of Biochemistry and Molecular Biology at Saint Louis University, examined SREBP-2, an important gene in the body, and zeroed in on the microRNA miR-33, which is expressed within SREBP-2.

Increasing the levels of miR-33 in the liver, scientists discovered, resulted in lower HDL cholesterol levels in an animal model; conversely, turning off miR-33, researchers found, had the effect of raising HDL levels.

Paralleling these results, four separate studies reported similar findings, adding to investigators' hope that better medications may be on the horizon for managing atherosclerosis. Scientists hope that future medications may prove to be more effective than statins alone by not only lowering LDL-cholesterol levels, but also increasing HDL levels.


'/>"/>

Contact: Carrie Bebermeyer
bebermcl@slu.edu
314-977-8015
Saint Louis University
Source:Eurekalert

Related medicine news :

1. Doctors need to help patients prepare better for health decisions
2. Microbiomes may hold key to better understanding of preterm birth
3. Friends, family detect early Alzheimers signs better than traditional tests
4. Better marker for breast cancer may reduce need for second surgeries
5. Prostate cancer community calls for better early detection and treatment
6. What can health-care facilities do to help patients better understand medical information
7. Centralized health care more cost-effective, offers better access to preventive services
8. University of Colorado Denver Business School study shows failure better teacher than success
9. Drug addicts get hooked via prescriptions, keep using to feel like a better person, research shows
10. Moderate drinking, especially wine, associated with better cognitive function
11. Better understanding of mapmaking in the brain
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2017)... ... ... San Diego physician and surgeon Dr. James Veltmeyer, author of the Medical ... the 52nd Congressional District currently held by Representative Scott Peters. , “I have ... age eleven after suffering homelessness and hardship in a distant land, I don’t just ...
(Date:8/21/2017)... (PRWEB) , ... August 21, 2017 , ... The ... Excellence Awards (IDSA IDEA®) 2017 Ceremony and Gala on Aug. 19, 2017 in ... one of the world’s most prestigious and rigorous design competitions. See all the winners ...
(Date:8/20/2017)... ... August 20, 2017 , ... ... Compliance Management System has assisted multiple clients in successfully passing audits such ... Organization Control Level 2 (AICPA SOC Level 2), and State Data Use Agreement ...
(Date:8/20/2017)... ... 20, 2017 , ... Are you an adult with gluten intolerance or Celiac ... be interested in participating in a research study that focuses on family interactions when ... about the relational aspects of adults who have gluten sensitivities who cohabitate with other ...
(Date:8/19/2017)... ... ... Western University of Health Sciences will host a special symposium and exhibition about ... on Wednesday, September 6, 2017. , The symposium will be from noon to 1 ... from 1 to 3 p.m. showcasing virtual reality education technology, high speed 3-D printing ...
Breaking Medicine News(10 mins):
(Date:8/15/2017)... , Aug. 15, 2017 AccuGenomics, Inc., ... , today announced that the company has provided ... University of North Carolina at Chapel Hill and to ... designed to characterize and quantify HIV reservoir and viral ... pharmacological intervention. The HIV Cure Center is a joint ...
(Date:8/11/2017)... DarioHealth Corp. (NASDAQ: DRIO), a leading global ... solutions, today announced that it will release its second ... a conference call at 9:00am ET. The Company will ... and its strategy and outlook for the remainder of ... Raphael , Chief Executive Officer, and Zvi Ben-David ...
(Date:8/8/2017)... 2017   Second-quarter ... (GAAP) loss per share from continuing operations ... increased 16 percent to $110 million ... percent to $161 million ... continuing operations increased 8 percent to $0.93 ...
Breaking Medicine Technology: